Key statistics
On Friday, Rafael Holdings Inc (RFL:NYQ) closed at 1.20, 7.14% above its 52-week low of 1.12, set on Dec 31, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.19 |
|---|---|
| High | 1.20 |
| Low | 1.17 |
| Bid | 1.17 |
| Offer | 1.28 |
| Previous close | 1.20 |
| Average volume | 70.00k |
|---|---|
| Shares outstanding | 51.76m |
| Free float | 30.89m |
| P/E (TTM) | -- |
| Market cap | 62.12m USD |
| EPS (TTM) | -0.8471 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Announcements
- Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results
- Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
- Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors
- Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old
- Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)
- Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
- Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
- Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
- Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
- Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
More ▼
